Grail (GRAL) Change in Accured Expenses (2023 - 2026)
Grail's (GRAL) quarterly Change in Accured Expenses came in at $5.6 million in Q2 2026, up 203.67% on a YoY basis from $1.8 million in Q2 2025, and up 203.88% quarter-over-quarter from -$5.4 million in Q1 2026.
Analysis
Grail (GRAL) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Change in Accured Expenses for 4 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Accured Expenses rose 203.67% year-over-year to $5.6 million; the trailing twelve-month figure through Jun 2026 stood at $15.1 million (up 312.91% YoY), and the FY2025 full-year result was $6.5 million, up 149.98% from the prior year.
- Change in Accured Expenses grew to $5.6 million in Q2 2026 per GRAL's latest filing, from -$5.4 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $16.1 million in Q3 2024 and bottomed at -$14.7 million in Q4 2024.
- Historically, Change in Accured Expenses has averaged $383333.3 across 4 years, with a median of -$477000.0 in 2023.
- The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses sank 9234.78% in 2024, then jumped 203.67% in 2026.
- Over 4 years, Change in Accured Expenses stood at $161000.0 in 2023, then tumbled by 9234.78% to -$14.7 million in 2024, then soared by 137.82% to $5.6 million in 2025, then advanced by 0.18% to $5.6 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $5.6 million, -$5.4 million, and $5.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -39.33 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 142.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -24.00 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 44.29 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 14.68 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 25.08 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | -205,000.00 |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 821,000.00 |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 1.01 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 5.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.57 Mn |
| Mar 31, 2026 | -5.36 Mn |
| Dec 31, 2025 | 5.56 Mn |
| Sep 30, 2025 | 9.37 Mn |
| Jun 30, 2025 | -5.38 Mn |
| Mar 31, 2025 | -3.11 Mn |
| Dec 31, 2024 | -14.71 Mn |
| Sep 30, 2024 | 16.07 Mn |
| Jun 30, 2024 | -13.17 Mn |
| Mar 31, 2024 | -1.12 Mn |
| Dec 31, 2023 | 161,000.00 |
| Oct 1, 2023 | 10.69 Mn |